Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit) Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Cumulative Effect, Period of Adoption, Adjustment	Total
Balance, beginning of period at Dec. 31, 2020	$ 12	$ 265,478		$ 13,765	$ 2,354		$ 281,609
Balance, beginning of period (in shares) at Dec. 31, 2020	118,854,249
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				8,533			8,533
Foreign currency translation adjustments					(1,201)		(1,201)
Dividend		(110,033)					(110,033)
Repurchase and retirement of common stock	$ (2)	(64,936)					(64,938)
Repurchase and retirement of common stock (in shares)	(21,666,653)
Stock-based compensation expense		1,464					1,464
Balance, end of period at Apr. 03, 2021	$ 10	91,973		22,298	1,153		115,434
Balance, end of period (in shares) at Apr. 03, 2021	97,187,596
Balance, beginning of period at Dec. 31, 2020	$ 12	265,478		13,765	2,354		281,609
Balance, beginning of period (in shares) at Dec. 31, 2020	118,854,249
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)							(56,361)
Balance, end of period at Oct. 02, 2021	$ 12	377,649		(42,596)	430		335,495
Balance, end of period (in shares) at Oct. 02, 2021	119,849,589
Balance, beginning of period at Apr. 03, 2021	$ 10	91,973		22,298	1,153		115,434
Balance, beginning of period (in shares) at Apr. 03, 2021	97,187,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(53,598)			(53,598)
Foreign currency translation adjustments					164		164
Net proceeds from initial public offering	$ 2	399,262					399,264
Net proceeds from initial public offering (in shares)	23,000,000
Repurchase and retirement of common stock	$ (1)	(216,699)					(216,700)
Repurchase and retirement of common stock (in shares)	(12,264,438)
Issuance of restricted stock in connection with the Reorganization	$ 1	(1)
Issuance of restricted stock in connection with the Reorganization (in shares)	8,340,126
Issuance of common stock upon conversion of Class B units	4,145,987
Stock-based compensation expense		75,511					75,511
Balance, end of period at Jul. 03, 2021	$ 12	350,046		(31,300)	1,317		320,075
Balance, end of period (in shares) at Jul. 03, 2021	120,409,271
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(11,296)			(11,296)
Foreign currency translation adjustments					(887)		(887)
Retirement of restricted stock (in shares)	(559,682)
Stock-based compensation expense		27,603					27,603
Balance, end of period at Oct. 02, 2021	$ 12	377,649		(42,596)	430		335,495
Balance, end of period (in shares) at Oct. 02, 2021	119,849,589
Balance, beginning of period at Dec. 31, 2021	$ 12	401,846		(48,583)	370		353,645
Balance, beginning of period (in shares) at Dec. 31, 2021	119,445,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				(2,840)			(2,840)
Foreign currency translation adjustments					1,220		1,220
Issuance of common stock	$ 1	269,099					269,100
Issuance of common stock (in shares)	13,800,000
Repurchase and retirement of common stock	$ (1)	(257,662)					(257,663)
Repurchase and retirement of common stock (in shares)	(13,800,244)
Retirement of restricted stock (in shares)	(53,961)
Issuance of common stock upon release of restricted stock units (in shares)	78,341
Stock-based compensation expense		16,925					16,925
Balance, end of period at Apr. 02, 2022	$ 12	430,208	$ (291)	(51,714)	1,590	$ (291)	380,096
Balance, end of period (in shares) at Apr. 02, 2022	119,469,747
Balance, beginning of period at Dec. 31, 2021	$ 12	401,846		(48,583)	370		353,645
Balance, beginning of period (in shares) at Dec. 31, 2021	119,445,611
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)							13,339
Balance, end of period at Oct. 01, 2022	$ 12	438,698		(35,535)	(5,140)		398,035
Balance, end of period (in shares) at Oct. 01, 2022	117,121,134
Balance, beginning of period at Apr. 02, 2022	$ 12	430,208	$ (291)	(51,714)	1,590	$ (291)	380,096
Balance, beginning of period (in shares) at Apr. 02, 2022	119,469,747
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				4,303			4,303
Foreign currency translation adjustments					(3,917)		(3,917)
Repurchase and retirement of common stock		(15,000)					(15,000)
Repurchase and retirement of common stock (in shares)	(2,026,231)
Issuance of common stock upon release of restricted stock units (in shares)	104,042
Stock-based compensation expense		16,429					16,429
Balance, end of period at Jul. 02, 2022	$ 12	431,637		(47,411)	(2,327)		381,911
Balance, end of period (in shares) at Jul. 02, 2022	117,547,558
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)				11,876			11,876
Foreign currency translation adjustments					(2,813)		(2,813)
Repurchase and retirement of common stock	$ (15,000)
Repurchase and retirement of common stock (in shares)	(2,026,231)
Retirement of restricted stock (in shares)	(426,424)
Stock-based compensation expense		7,061					7,061
Balance, end of period at Oct. 01, 2022	$ 12	$ 438,698		$ (35,535)	$ (5,140)		$ 398,035
Balance, end of period (in shares) at Oct. 01, 2022	117,121,134